PerioChip®

A biodegradable periodontal chip releasing 2.5mg Chlorhexidine Gluconate over a period of 10 days

Novel OTC formulation

Novel Formulation of a well-known US OTC Brand

Omeprazole DR Tablets

Proprietary Delayed Release Tablet Formulation of Omeprazole OTC

Complex Injectable
(Co-development)

Complex injectable product equivalent to a well-known brand in the oncology field; Co-developed with CSPC Pharma

ViePax® XR
(Venlafaxine XR tablets)

Proprietary Extended Release Tablet formulation bioequivalent to capsule Effexor XR capsules

Dexcel Pharma readily affirms its commitment to maintaining the highest standards of ethical conduct and strict compliance with the guidelines, rules, and regulations that govern our business practices. Our core values – integrity, ethical behavior, commitment to quality, and professionalism – demonstrate our pledge to excel in every aspect of our business.

 

As part of this commitment, Dexcel Pharma has established certain principles designed to guide employees and business partners in their business-related actions to avoid potential misconduct, including a complete ban on exerting any kind of bribery or improper influence in any type of business transaction.

 

Dexcel Pharma expects all of its employees and business partners to conduct themselves in compliance with both their legal and ethical responsibilities in all daily business operations. Dexcel Pharma is unreservedly committed to the foregoing and will forgo any business transactions that would violate it.

 

We look forward to working with our business partners in a manner which will allow us to demonstrate our commitment to our principles of ethical behavior and our record as an excellent corporate citizen.